Removal of erythrocytes from blood specimens before performing clinical chemistry tests on plasma or serum has been a basic procedure for many years. Particulate matter causes problems in analytical methods and red blood cells occupy a significant volume. Lysis of the cells releases substances in different concentrations from those in plasma and some cell constituents interfere in assay techniques, e.g. haemoglobin in colorimetric methods. For most assays, therefore, the homogeneous medium of plasma or serum has been considered to be preferable. One of the few exceptions to this has been glucose assay, in which either whole blood or plasma has been used. The advantages of whole blood are in the time saved in not having to separate blood components and in not requiring the availability of a centrifuge. In a laboratory environment, this may not matter too much, but in a clinic or site of near-patient testing, it assumes greater importance. For this reason, virtually all of the near-patient systems for glucose employ whole blood, applied directly from a finger-prick, as the sample.
DIFFERENCES BETWEEN WHOLE BLOOD AND PLASMA GLUCOSE CONCENTRATIONS
Glucose is considered to pass freely from red cells to plasma and vice versa, but measurements of whole blood glucose by conventional methods have given results lower than measurements of plasma glucose in the same sample. This has been attributed to the different water contents of red cells and plasma (approximately 71% and 93%, respectively). In other words, the glucose concentration in red cell water and plasma water is similar. Glycolysis in the red cells might be responsible for a small difference, but the discrepancy in water content roughly equals the usually quoted average difference of 10-15% between whole blood and plasma glucose concentration. However, experimental work has shown wide variation in this difference, ranging from 4-47% in some studies.t-" Morrison and Fleck found no simple numerical relationship between plasma and whole blood glucose and no correlation with haematocrit. 2 However, Holtkamp et al. claimed that good correlation was found only when protein-free filtrates were used for the glucose assays." They did not explain this, but the ferricyanide method they used for glucose assay is known to be non-specific and to be affected by other agents that might be removed by protein precipitation. On the other hand, Morrison and Fleck used a more-specific glucose oxidase technique, but this too can be subject to interference at the peroxidase-chromogen step by substances such as glutathione released from red cells or by, for example, uric acid or ascorbic acid present in plasma at higher than normal concentrations. Nevertheless, Meites and SanielBanrey, using a direct glucose oxidase method without deproteinization, were able to demonstrate a difference between plasma and whole blood glucose and also found a relationship with haematocrit." The literature is, therefore, rather confusing, and little confidence can be placed in some of the older reports when less specific methods were employed. However, even the newer methods described below do not exhibit uniformity of relationship between whole blood and plasma results, and possible reasons for this will be discussed later.
CURRENT METHODS FOR WHOLE BLOOD GLUCOSE
Nowadays, measurement of whole blood glucose mostly involves the use of some sort of dedicated analyser, either in the laboratory or beside the patient. Several different types of instrument are on the market and there are important differences between them (Table 1 ).
The YSI There are different versions of the YSI glucose analyser in existence (YSI Ltd, Hampshire, UK), but all are based on the Clark electrode. In the YSI, the electrode face is covered by a three-layer membrane comprising an outer polycarbonate layer and an inner cellulose acetate layer. Between these is sandwiched immobilized glucose oxidase. The electrode is in contact with a buffer solution into which either a whole blood or a plasma sample is injected and diluted. There is no lysis of erythrocytes. Some of the glucose passes through the polycarbonate membrane to react with the glucose oxidase, resulting in hydrogen peroxide formation.
The hydrogen peroxide diffuses through the smaller-pored cellulose acetate membrane, which excludes compounds of molecular weight above about 200, and is oxidized at the platinum anode with production of electrons. When steady state is reached, the electron flow is proportional to hydrogen peroxide concentration and hence to the glucose concentration in the solution in contact with the glucose oxidase.
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The instrument is calibrated using an aqueous glucose standard solution. Whole blood results 1995: 32 tend to be lower than figures for plasma sampled from the same specimen and the effect is haematocrit-dependent, but typically 10 to 150/0 different ( Fig. 1) . The manufacturer provides correction factors and nomograms for converting the expression of results from blood to plasma and vice versa.
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The Analox glucose analyser The Analox glucose analyser (Analox Instruments Ltd, London, UK) utilizes an oxygen electrode in contact with a buffered glucose oxidase reagent in which the sample is injected and diluted. The rate of oxygen consumption in the glucose oxidase reaction is measured as an indication of the amount of glucose present. Plasma is usually sampled on this instrument, but whole blood can also be used. However, as oxygen is being measured in this technique, rather than hydrogen peroxide, prior treatment of whole blood with nitrite is necessary to convert the haemoglobin to methaemoglobin to prevent changes in oxyhaemoglobin affecting the measurement. The whole blood sample can be presented with lysed or unlysed red cells. There is a haematocritdependent difference between results for plasma and intact whole blood (Fig. 1) The APEC In the APEC glucose analyser (APEC, Danvers, MA, USA), the red cells are lysed and the haemoglobin converted to methaemoglobin before being passed repeatedly through a tube containing immobilized glucose oxidase. The oxygen uptake is measured by means of a conventional oxygen electrode in contact with the reaction mixture. The method is calibrated against an aqueous glucose standard, the viscosity of which is increased by the addition of polyvinylpyrrolidone (PVP). The manufacturer claims that whole blood and plasma give very similar results, with no haematocrit effect.
The HemoCue
The HemoCue blood glucose analyser (HemoCue Ltd, Sheffield, UK) is a near-patient testing device that takes whole blood directly from a fingerprick into a plastic disposable cuvette containing dry reagent. The erythrocytes are lysed and glucose is oxidized in the presence of glucose dehydrogenase with reduction of NAD to NADH, which is linked to a colour reaction, according to the method described by Banauch et al. 8 In the author's experience, the differences between results for plasma and whole blood on the HemoCue are smaller than might conventionally be expected ( Fig. 1 ) and are largely unaffected by the haematocrit.? The system is calibrated by the manufacturer, who uses the YSI and an automated glucose dehydrogenase method, with deproteinization, as reference methods.
has claimed that the method is unaffected by haernatocrit," but another group observed an effect. 7 Strip-test methods These are availab' fror-i several different manufacturers and usually consist of a reagent pad impregnated with glucose oxidase [1:1.1 chromogenic agents, but one of the newer types, the Glucotide (Bayer Diagnostics, Basingstoke, UK), is based on the hexokinase method. The pad is either sponge-like, with a restrictive pore size, or is covered by a mesh or membrane so that, when a drop of blood is applied to the surface, plasma soaks through into the reagent layer and red cells are retained on the surface. In the older techniques, the red cells usually have to be removed by wiping or blotting; in the newer methods, this is often avoided by measuring the colour change through a window on the underside
:::2: Calibration of all the strip-test systems is done in the factory and usually set so that patients' specimens give results equivalent to whole blood concentration. Aqueous glucose standards, with viscosity and other differences compared with blood, will not read correctly on such systems. Most of these methods are affected by haematocrit, but to a varying degree.!
In situ monitoring Several devices have been described for in situ monitoring of blood glucose, but none has yet found routine application. 10 They usually rely on special modifications of techniques employed for in vitro measurement of glucose, but may be positioned at sites other than in the blood, e.g. in subcutaneous tissue. They have to respond and be calibrated in such a way that they reflect changes in blood glucose.Pi'?
Non-invasive techniques It is now possible to measure blood glucose by means of non-invasive techniques. An example is the use of near-infrared spectra. Near-infrared light is shone through a part of the body with reasonable blood circulation, e.g. a finger, and the absorption measured at selected wavelengths. Computer studies of such spectra are then used to analyse the results and to apply corrections to minimize interferences. Nevertheless, the basic calibration of the instrument still depends on performing a large number of glucose assays on blood samples from different subjects by means of a conventional reference method.P'?" Calibration and reference methods for whole blood glucose assays From the information given above for the individual analytical methods, it can be seen that most laboratory glucose analysers employ aqueous standards of known glucose concentration for basic calibration of the instrument. The APEC includes PVP to compensate for viscosity effects. Aqueous standards are suitable AIlIl Clin Biochem 1995,32 provided that blood specimens behave in an analogous manner in the assay system. In practice, this may be an invalid assumption, in which case calibration of the system by means of a reference method may be more appropriate.
Isotope dilution/mass spectrometry techniques have been proposed as 'definitive' methods for glucose measurement in serum.P'?? but have not been applied to whole blood. The hexokinase method on a protein-free filtrate has been put forward as a reference method for plasma glucose" and, for routine purposes, has been applied directly to plasma without deproteinization. A version of this technique with a deproteinization step is used by Boehringer Mannheim for assigning glucose values to whole blood specimens during calibration of its striptest systems.
The introduction of the YSI glucose analyser in the mid-1970s and its ability to accept whole blood as a sample has led to its being used as a convenient reference method for other whole blood glucose procedures, although the original evaluations of this instrument were apparently performed with plasma samples. The Glucometer systems and their various test strips (Bayer Diagnostics, Basingstoke, UK), the Lifescan OneTouch II (Lifescan, Buckinghamshire, UK) and the ExacTech are examples of strip-test systems that use the YSI as a reference method.
When a reference method is used to calibrate another method, it is usual to assay, by both methods, a range of blood samples from different subjects with a spread of glucose levels and then to quantify the responses of the proposed method according to the values obtained by the reference method. However, if for example, the YSI is used as the reference technique, its results will be affected somewhat by the haematocrit of the blood specimens, by any gross deviations of plasma protein concentration or by high lipid levels. Most other methods will also be affected by these factors, but the degree of influence may not be the same. For example, in a polycythaemic patient the YSI result would be expected to reflect the reduced water content of the blood and to give a significantly lower result than for a plasma measurement, but still to give an accurate estimate of the glucose concentration in the total blood specimen. However, many strip-test methods would produce an even lower result because the large volume of red cells would probably interfere with the flow of plasma through the surface membrane and into the reagent layer, slowing the colour development. Calibration, therefore, involves making assumptions about the nature and behaviour of the specimens to be analysed and most methods are set up to give reasonably accurate results in subjects whose blood conforms to certain criteria of normality. The opportunities for anomalies with a whole blood sample are greater than for plasma, both because of the nature of the specimen itself and also because of the analytical mechanisms that have to be employed to permit analysis of whole blood specimens. Problems of this kind are more prevalent with homemonitoring systems than with laboratory analysers and occasionally one comes across particular patients who seem incompatible with certain monitoring systems. However, gradual improvements are being made to these techniques and they are becoming less susceptible to influences of this nature.
Even in situ and non-invasive monitoring techniques which do not come into contact with whole blood, still need to be calibrated by comparison with a reference method measuring whole blood glucose at the same time as the sensor's response is being recorded. Of course, the validity of such a method also depends on the demonstration of good correlation between the response of the sensor, wherever it may be sited (e.g. subcutaneously), and the blood values obtained by the reference method. In fact, plasma glucose by a glucose oxidase/oxygen electrode analyser has mostly been used as a reference method for this type of system, eliminating the influence of haematocrit. [11] [12] [13] Glucose activity versus concentration Although the concentration of glucose in mmol/L of red cells is lower than in the surrounding plasma, the activity, expressed as mmol/kg of water, should be the same in both, assuming free passage of glucose between them. It is this activity that is thought to be important physiologically and if reactions are influenced by the activities of the reactants in solution, rather than by their concentrations in the total volume, then a directreading method such as the NOVA should give a measure of glucose activity and the result should be the same whether whole blood or plasma is sampled. Fogh-Andersen et al. found this to be substantially true for the NOVA, but some haematocrit effect was observed." This means that it is incorrect to express such direct-reading results as mmol/L of blood without applying a downward correction to take account of nonwater constituents of significant volume, such as protein. On the other hand, if a fraction of the glucose were bound, making it unable to exert its potential activity, an opposing upward correction would be needed to express results of total glucose in mmol/L of blood. The theoretical relationship between direct assays of glucose concentration in the water of the sample and indirect assays giving concentration in the whole specimen is illustrated in Table 2 . One could equally legitimately show the relationship from the stand-point of a fixed glucose concentration of 10· 0 mmol/L in the whole specimen, in which case the figures for the concentration in the water of the sample would become progressively higher than 10· 0 mmol/L as the non-water fraction increased.
The YSI uses a similar electrode system to the NOVA, but the sample is diluted before the assay takes place. It is still responding to the activity of glucose, but in this case it is the activity in the dilute solution in contact with the electrode. Some of this glucose will have been drawn out of the still-intact red cells by the gradient induced by the dilution and the validity of the assay depends on this redistribution having reached equilibrium by the time the reading is taken. In this system, the lower the water content of the original sample, the greater the dilution of glucose activity before analysis and the lower will be the reported concentration in the original specimen derived from comparison with the aqueous standard. This is similar to the situation with ion-selective electrodes for sodium when a specimen very high in protein or lipid is sampled. The direct-reading type responds to the sodium concentration or activity in the water of the sample, which may be normal; but the indirect type, where a measured volume of the specimen is diluted, gives a low result equating to the low concentration in the overall sample. In the case of whole blood glucose, the situation is further complicated by the presence of the erythrocytes which, despite free movement of glucose across their membranes, may possibly still exert an influence on the analysis."
Both the Anal ox and APEC techniques involve dilution of a measured aliquot of the specimen and the whole of this aliquot is allowed to react with glucose oxidase. These methods would, therefore, be expected to yield results reflecting the glucose concentration in the whole sample. In the HemoCue, there is no sample dilution, but the disposable reaction cuvette accepts a fixed volume of blood and all of the glucose in this should be available to participate in the assay reaction and colour development. Consequently, the result would be expected to be proportional to the overall concentration of glucose in the lysed blood sample, rather than to the activity in the sample water. The strip-test methods, generally speaking, seem to be responding to glucose concentration, but in plasma rather than in whole blood, the reacting sample volume being controlled to some extent by the absorbing capacity of the reagent layer.
Clearly, the relationship between activity and concentration of a substance in a whole blood or plasma specimen is a complex one. It has been addressed more fully for sodium and potassium and a recommendation made that ion-selective electrode results should be factorized to give a figure in keeping with the conventionally measured concentration in the total sample.l? Although physiologically, activity was considered to be the more important measure, the decision was influenced by the need for comparability between different methods and the necessity to change familiar reference ranges if results were to be expressed in terms of activity.
Lysed versus intact whole blood and the effect of haematocrit In methods where the blood sample is diluted without lysis of the erythrocytes, a small residue of glucose will remain within the cells at equilibrium. However, the fairly high dilutions of one in 25 on the YSI and one in 50 on the Analox should reduce this to a minimum and consumption of glucose in the assay reaction will also tend to draw it out of the cells. Of course, these methods assume that all the glucose is freely diffusible and that sufficient time is allowed for diffusion to reach equilibrium. Any nondiffusible glucose bound to cell components would not be measured; but in methods involving red cell lysis it is conceivable that some bound glucose could be released and make a contribution to the measured whole blood glucose. This would go some way towards explaining why procedures involving red cell lysis, including a version on the Analox, tend to give results for whole blood that are rather closer to plasma levels measured by the same method."
The effect of haematocrit is closely linked to the water content of the sample in some methods, but in the strip-tests it is probably the nature of the barrier used to prevent red cell entry into the reagent layer that determines the extent of the effect. There have been numerous reports of this phenomenon and certain makes of strip are more susceptible than others. 5,20-23 However, the author has observed some general improvement in the newer strips coming on to the market.
Presumably the effect stems from greater numbers of red cells causing a reduction in flow of plasma into the reagent pad, resulting in less glucose being available for reaction. Whatever the cause, the effect can be quite marked at low and high haematocrits, rendering results by some techniques invalid for anaemic or polycythaemic patients. For this reason, few of the strip-test methods are considered to be suitable for testing neonates.
Theoretically, the direct-reading electrode systems should be unaffected by haematocrit. Some reports claim this to be the case,6.24 but one group observed an effect and speculated that the red cell membranes might be inhibiting glucose flux into the electrode." It seems, therefore, that the reasons for the haematocrit effect are different in different methods and this is consistent with the observed wide variation in magnitude of the effect.
The influence of oxygen tension As oxygen is a reactant in glucose oxidase methods, differences in oxygen tension can theoretically influence the results of the assay. In practical terms, this does not generally present a significant problem for laboratory assays in which adequate amounts of dissolved oxygen are present in the reagents. In methods where red cell lysis releases haemoglobin capable of binding oxygen, it is usual to convert it to methaemoglobin to nullify its influence. It can, however, be more problematical for dry chemistry systems where the oxygen tension of the specimen assumes greater importance. Some systems are more susceptible to this effect than others.i' The ExacTech is calibrated specifically for measuring glucose in fresh capillary blood and will give incorrectly high results for venous blood." A recent paper documented considerable influence of both p02 and pH of blood on ExacTech results.??
Hyperosmolar hyperglycaemia
In significantly hyperosmolar hyperglycaemia, there have been several cases of falsely low glucose concentration figures being produced by certain near-patient testing systems." In another report, confirming this observation, it has been suggested that visual readings of test strips are more reliable than meter readings in this situation."
Whole blood or plasma glucose? Several groups of workers have advocated measuring plasma rather than whole blood glucose.l v However, Meites argued that whole blood glucose is more relevant physiologically because the free exchange between red cells and plasma, gives the tissues, that it bathes, free access to virtually all the glucose in whole blood."
Analytically, plasma presents fewer problems than whole blood, once the inconvenience of removing the cells has been overcome; but if the physiologically important entity is the glucose activity or concentration in the water of the sample, and we are able to measure that, it is irrelevant which fraction is assayed, as the result should be the same in both red cells and plasma. This requires the use of a direct-reading electrode, but most laboratory analysers still involve dilution of the specimen and are unable to give results in this form. We are, therefore, restricted in general to expressing glucose in terms of concentration in the entire specimen. Doing this for plasma, rather than for whole blood, eliminates one of the variables, i.e. haematocrit, and should give more reliable results.
The dry reagent-strip tests purport to be measuring whole blood glucose when they are really measuring plasma glucose. It seems that, because whole blood is applied to the strip, the manufacturers feel obliged to report the result in those terms, although it is strictly incorrect to do so. On the other hand, neither would it be a true Blood glucose measurement 7 measure of plasma glucose, because the response of the strip is, in most cases, influenced by the erythrocytes applied to its surface. It is our inability precisely to quantitate these complex phenomena that makes one realize how much of an approximation to the truth these strip-test systems involve. In most cases they produce a satisfactory result, but they should not be used for diagnostic purposes nor relied upon solely in other critical situations.
CONCLUSION
The ability to measure glucose in whole blood makes the assay quick and convenient, especially for near-patient use. It does, however, introduce problems to the analytical process that have been only partially solved. A major difficulty is the difference in volume of red cells from one blood sample to another and some methods are insufficiently robust to be unaffected by this. Assumptions made for calibration purposes about water and non-water content of specimens do not always apply and this leads to erroneous results. Furthermore, methods involving lysis of erythrocytes seem to exhibit a different whole blood/plasma relationship in results that is not consistent with the usual explanation of differing water content. One can speculate that the lysis may be releasing some bound glucose or other substances that might interfere in the assay, but the reason is not yet clearly understood. Now that it is possible to obtain a measure that reflects the activity of glucose in the water of the specimen, the situation is further complicated by discussions as to whether results should be expressed in this way, rather than as concentration in the total sample. From a practical point of view, it is not yet feasible for everyone to do this and, if the precedent established for sodium and potassium is to be followed, we should continue with conventional concentration values at present. This will, of course, necessitate assumptions again being made about the water content of samples to permit the factorization of results from direct-reading systems to convert them to concentration values.
Given the sophistication of modern technology and the simplicity of an analyte such as glucose, one might have expected that we could be confident about what we are measuring and in the accuracy of most of the techniques currently in use. From the evidence available, clearly this is not so and the situation is aggravated by the lack of a universally accepted reference method for whole blood glucose. It is to be hoped and expected that developments, particularly in the field of sensors, will help to rationalize and unify this area of analysis; but it is likely to be some time before all the theoretical concepts and practical aspects are satisfactorily reconciled. In the meantime, those involved in blood glucose measurement, laboratory workers, clinical staff, equipment manufacturers and even patients, should be made aware that it is not such an exact science as they might have thought, and there is good reason for us to look critically at the methods we use.
